As of 2024-12-11, the EV/EBITDA ratio of Horizon Therapeutics PLC (HZNP) is
27.92.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HZNP's latest enterprise value
is 26,724.37 mil USD. HZNP's TTM EBITDA according to its financial statements is
957.03 mil USD. Dividing these 2
quantities gives us the above HZNP EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
5.4x - 11.2x |
5.7x |
| Forward P/E multiples |
12.1x - 20.9x |
12.5x |
| Fair Price |
22.25 - 68.12 |
31.96 |
| Upside |
-80.9% - -41.4% |
-72.5% |